PosterSessionOnline

THE EUROPEAN SOCIETY OF CLINICAL MICROBIOLOGY

34th ECCMID

27-30 April Barcelona

N. Poster

Poster title

Applicant name

Status


P-0002	Re-engagement of formerly incarcerated people living with HIV lost to care	Maximo Brito	Received

P-0011	Whole genome sequencing approach to identify HIV-1 drug resistance in clinical samples	Sofiane Mohamed	Received

P-0012	Immune responses after mpox infection or vaccination in a cohort of HIV-PrEP users	Aleksandra Pettke	Received

LB-0018	Inhibition of the outer membrane protein OprF: a novel target to counteract carbapenem resistance in Pseudomonas aeruginosa	Nicolas Helsens	Received

LB-21	Superior immunogenicity of self-amplifying mRNA vs standard mRNA COVID-19 vaccine	Keith Veitch	Received

LB-0026	Pharmacokinetics and safety of the SARS-CoV-2 monoclonal antibody sipavibart are consistent with those of tixagevimab/cilgavimab	Kaitlyn Malchione	Received

LB-0031	Early treatment with pyronaridine-artesunate reduced time to sustained symptom resolution in patients with mild-to-moderate COVID-19 not requiring supplemental oxygen	Chung Ju	Received

LB-0034	A nationwide randomised trial to confirm effectiveness of electronically delivered nudges in increasing influenza vaccination uptake among older adults: the NUDGE-FLU-2 trial	Niklas Dyrby Johansen	Received

LB-0040	Mid-season 2023-2024 influenza vaccine effectiveness in children and elderly: a register-based cohort analysis, Finland	Hanna Nohynek	Received

LB-42	Intravenous brincidofovir rapidly clears adenoviremia in immunocompromised patients: interim results from Phase 2a ATHENA study	Hiroko Iwasaki	Received

LB-43	Clinical impact of laboratory stewardship intervention for plasma metagenomic next-generation sequencing infectious disease testing in a multi-centre paediatric hospital system	Denver Niles	Received

LB-0046	Immunogenicity and reactogenicity of fractional vs full booster doses of COVID-19 vaccines: a non-inferiority, randomised, double-blind, Phase 4 clinical trial in Brazil	Julio Henrique Rosa Croda	Received

P-0058	Hepatitis B infection and immunity in Timor-Leste: a population-representative serological survey	Paul Arkell	Received

LB-0066	Clonal dissemination of methicillin-resistant Staphylococcus saprophyticus and Staphylococcus haemolyticus among different sheep farms: an emerging threat to animal and public health	Chahrazed Belhout	Received

P-0067	A large outbreak of hepatitis A in a northern community in Canada 2021-2022: public health interventions and immunisation in a remote context	Yassen Tcholakov	Received

LB-0069	First genomic description of pig-to-pig transmission of an emerging and extensively drug-resistant Staphylococcus borealis in Spain	Idris Nasir Abdullahi	Received

P-0078	Beyond influenza and SARS-CoV-2: advancing respiratory sentinel surveillance in Sweden	Carmen Espinosa-Gongora	Received

P-0079	Prophylactic efficacy of CD388, a novel drug-Fc conjugate (DFC), in an influenza A/H3N2 human challenge model	Roxana Rojas	Received

P-0093	Clinical characteristics, complications, and predictors of serious outcomes among adult outpatients with respiratory syncytial virus infection	SUWEI WANG	Received

P-0095	Clinical assessment of a fully automated RT-PCR assay for the qualitative detection of parainfluenza virus 1,3 and 2/4 in human nasal/throat swabs under IVDR	Ulrich Eigner	Received

P-0096	Evaluation of the clinical performance of a fully automated RT-PCR assay for the qualitative detection of RSV and hMPV in human nasal/throat swabs and bronchoalveolar lavage under IVDR	Ulrich Eigner	Received

P-0100	Cost-effectiveness of protective equipment stockpiles for reducing essential worker absenteeism in a pandemic: a modelling study	Nadia Montazeri	Received

P-0104	Comparison of three commercial nucleic amplification tests for influenza A testing in a symptomatic patient population	Salma Kodsi	Received

P-0106	Influenza A and B viral loads are higher in nasopharyngeal swabs compared to mid-turbinate swabs	Steffen Wildum	Received

P-0110	Respiratory syncytial virus incidence trends during omicron COVID pandemic in older adults: a community-based prospective study	Wendelyn Bosch	Received

P-0125	Estimation of RSV-attributable mortality in adults in Italy between 2015 and 2019	Giuseppe Pietro Innocenti	Received

P-0127	Changes in influenzavirus-A/B and human respiratory syncytial virus seasonality and activity during the COVID-19 pandemic in Switzerland	Karoline Leuzinger	Received

P-0138	Economic burden of respiratory syncytial virus (RSV) and unspecified lower respiratory tract infection (UBP) during RSV season in adults in Germany (2015-2018): a health claims analysis	Caroline Beese	Received

P-0139	Subtyping and whole-genome sequencing of influenza A/B viruses using pan-subtype primers, widely-used library prep reagents, and cloud-based data analysis	Robert Schlaberg	Received

P-0159	Further characterisation of vaccine efficacy in infants from a Phase 3 RCT of a bivalent prefusion F RSV vaccine administered during pregnancy	Emma Shittu	Received

P-0162	Neutralising monoclonal antibodies raised against highly conserved influenza hemagglutinin, neuraminidase, and matrix epitopes may offer novel cocktail therapeutic strategies	Clara Sei	Received

P-0165	CD388, a drug-Fc conjugate, shows long half-life in early clinical studies	Ruben Faelens	Received

P-195	Antigen-specific immunoassays improve the serological staging of cytomegalovirus infection	David Springer	Received

P-0197	Steroid pulse therapy for severe fever with thrombocytopenia syndrome patients may not improve prognosis: retrospective analysis with overlap weighting using a national inpatient database	Satoshi Kutsuna	Received

P-0214	Clinical importance of Alongshan virus, a new tick-borne Flaviviridae virus: a retrospective serological and molecular study	Florian Tagini	Received

P-0218	Prospective evaluation of serum cytokines and musculoskeletal ultrasound as surrogate markers for chronic post-chikungunya rheumatism	Hugh Watson	Received

P-0220	Increased likelihood of leukopenia, thrombocytopenia, and other characteristics in Crimean-Congo haemorrhagic fever patients: a systematic review and analysis of clinical factors that indicate infection	Joseph Alberts	Received

P-0236	Co-detection of RNA and DNA viruses in a single library prep and enrichment workflow	Robert Schlaberg	Received

P-0252	Adjuvanted unconjugated highly conserved multi-epitope influenza peptide vaccine induced broadly reactive antibodies to multiple influenza viruses in pigs	Kellie Kroscher	Received

P-0260	Minor clinical sequelae and absence of viral persistence: an 8-month follow-up study of former mpox patients	Nicole Berens-Riha	Received

P-0261	Sero-catalytic and spatial modeling of dengue force-of-infection from age-stratified seroprevalence data in Timor-Leste	Paul Arkell	Received

P-0272	Verification of a new molecular point of care system for respiratory viruses for its use with two widely used transportation media	JUERGEN Becker	Received

P-0273	Enhancing pathogen detection in viral respiratory tract infections among individuals aged 55 years through expanded PCR panel testing	Jelena Feenstra	Received

P-0276	Clinical performance evaluation of a real-time PCR-based test for the detection of high-risk HPV genotypes	Jelena Feenstra	Received

P-0277	Establishing EBV load thresholds for predicting persisting EBV-DNAemia and associated disease	Svenia Schmid	Received

P-0279	Comparison of Allplex HPV28 and Anyplex II HPV28 Assays for the detection and genotyping of human papillomavirus	Karoline Leuzinger	Received

P-0295	Viral and inflammatory markers in sudden death caused by myocarditis: a retrospective bicentric study	Domitille Callon	Received

P-0303	Patterns of enterovirus infections in hospitalisations and outpatient visits in Denmark 2015-2022	Caroline Klint Johannesen	Received

P-0323	Recently published randomised controlled trials investigating treatments against COVID-19 displayed lower risk of bias: a systematic review and critical appraisal	Kavina Kudhail	Received

P-0328	Cross-sectional surveillance study of long COVID in Toyonaka city, Osaka Prefecture, Japan	Satoshi Kutsuna	Received

P-0340	Cost-effectiveness of oral nirmatrelvir/ritonavir in patients at high risk for progression to severe COVID-19 in the United States	Tendai Mugwagwa	Received

P-0341	Enhancing respiratory disease diagnosis: a comparative analysis of multiplex point-of-care PCR and antigen testing for SARS-CoV-2, influenza, and respiratory syncytial virus in Germany	Jordan Chase	Received

P-350	Recurrent ventilator-associated pneumonia in severe COVID-19 ARDS patients requiring ECMO support	CHARLES-EDOUARD LUYT	Received

P-0353	Real-world evidence comparing the risk of Delta and Omicron infection outcomes by SARS-CoV-2 antibody levels	Liz Southey	Received

P-0363	In vitro neutralisation of Pemivibart (VYD222) against Omicron sublineages	Pamela Hawn	Received

P-0365	Descriptive analysis of self-reported HRQoL using EQ-5D-5L among symptomatic outpatients with COVID-19 in the US during an Omicron predominant period	Xiaowu Sun	Received

P-0367	Sentinel cohort safety of AZD5156 (sipavibart/cilgavimab) from the phase 1/3 SUPERNOVA trial for COVID-19 prevention in participants with immune impairment	Kaitlyn Malchione	Received

P-0368	Developing a model for decision-making around antibiotic prescribing for patients with COVID-19 pneumonia in acute NHS hospitals during the first wave of the COVID-19 pandemic: qualitative results from the procalcitonin evaluation of antibiotic use in COV	Joanne Euden	Received

P-0369	Descriptive epidemiology of adverse events following mRNA COVID-19 vaccination in Curacao	Jonathan Lambo	Received

P-0374	Procalcitonin evaluation of antibiotic use in COVID-19 hospitalised patients: the PEACH study	Emma Thomas-Jones	Received

P-0375	Effect of co-formulation on pharmacokinetics of AZD7442, a monoclonal antibody combination against COVID-19	Kaitlyn Malchione	Received

P-0379	Serum AZD7442 (tixagevimab-cilgavimab) concentrations and in vitro IC50 values predict SARS-CoV-2 neutralising antibody (nAb) titres	Joe Jones	Received

P-0380	COVIDRIVE: a European public-private partnership for generating real-world evidence on the effectiveness of COVID-19 vaccines	Wendy Hartig-Merkel	Received

P-0381	High prevalence of immunocompromising conditions among patients with severe acute respiratory infection, including SARS-CoV-2: results from a multicentre, test-negative case-control study	Joe Jones	Received

P-0382	Immunocompromise, cancer and other comorbidities in patients with severe acute respiratory infection testing positive versus negative for SARS-CoV-2: a post hoc analysis of COVIDRIVE data from May 2021 to May 2023	Joe Jones	Received

P-0409	Continued increased risk of COVID-19 hospitalisation and death in immunocompromised individuals despite receipt of &8805;4 vaccine doses: updated 2023 results from INFORM, a retrospective health database study in England	Kaitlyn Malchione	Received

P-0414	Prospects for reducing the risk of emergence of SARS-CoV-2 variants from infections in immunocompromised individuals: a modelling approach	Joe Jones	Received

P-419	A Phase 1, concentration-QTc analysis shows bemnifosbuvir does not alter cardiac repolarisation	Jeannie Leung	Received

P-0421	Pharmacokinetics, safety, and tolerability of ensitrelvir, a novel oral inhibitor of 3C-like protease of SARS-CoV-2, in participants with hepatic impairment	Takayuki Katsube	Received

P-0423	Efficacy and safety of EDP-235 in non-hospitalised adults with mild or moderate COVID-19: results from the phase 2 SPRINT study	Scott Rottinghaus	Received

P-0426	Canadian healthcare and education workers hesitance to receive original and bivalent COVID-19 vaccines	Brenda L Coleman	Received

P-0429	Hamster model to evaluate post-COVID-19 condition treated with ensitrelvir: smell disorder	Ryoichi Tashima	Received

P-0437	Long-term cardiovascular, cerebrovascular, and thrombotic complications after SARS-CoV-2 Omicron vs Delta infection: a retrospective cohort study	Liang En Ian Wee	Received

P-0440	Long-term risk of death and cardiovascular events following COVID-19 vaccination or positive SARS-CoV-2 test amongst adult Singaporeans during Omicron	Liang En Ian Wee	Received

P-0445	Long-term neuropsychiatric sequelae of Delta versus Omicron SARS-CoV-2 infection	Calvin J Chiew	Received

P-0447	Live single-cycle SARS-CoV-2 vaccine elicits high protection and sterilising immunity	David Hauser	Received

P-448	Real-world performance of a single-use, analyser-free, molecular point-of-care test for COVID-19 used in the emergency department: results of a prospective trial (ED-POC)	Mary Chapman	Received

P-0454	Impact of treatment of COVID-19 with sotrovimab on post-acute COVID-19 syndrome: an analysis of national COVID cohort collaborative (N3C) data	Abbas Ali	Received

P-0456	A retrospective propensity-score-matched cohort study of the impact of procalcitonin testing on antibiotic use in hospitalised patients during the first wave of COVID-19 (PEACH study)	Jonathan Sandoe	Received

P-0470	SARS-CoV-2 infection and re-infection by Delta and Omicron variants in a population with low vaccine coverage	Rhys Wenlock	Received

P-0487	Surveillance and detection of SARS-CoV-2 in four national university campuses, the UniCoV Project: apps, antigens, saliva, wastewater, and participation	John Mac Sharry	Received

P-0489	Dual antiviral therapy can be effective for treatment of protracted SARS-CoV-2 infection in immunocompromised hosts	Jessica Little	Received

P-0495	Epidemiology of bacterial co-infections in COVID-19 associated pulmonary aspergillosis patients in a tertiary-care teaching hospital in Mexico City.	BENJAMIN VALENTE ACOSTA	Received

P-0500	Associations of COVID-19 control measures, the incidence of pneumonia and various respiratory pathogens in Finland, 2020-2023	Hanna Nohynek	Received

P-0509	Proteomic insights into the impact of COVID-19 on peripheral blood mononuclear cells in kidney transplant recipients	Giuseppe G. F. Leite	Received

P-0514	Comparing the disease burden of COVID-19 in-patients with and without high risk factors for severe outcomes: a retrospective study using routine hospital data	Dominik Thiele	Received

P-525	Safety of a self-amplifying mRNA COVID-19 vaccine, ARCT-154	Igor Smolenov	Received

P-0532	A polymersome COVID-19 booster is safe and immunogenic in pre-vaccinated healthy volunteers and confers exceptional thermostability	Katherine Schultheis	Received

P-0536	COVID-19 mRNA Vaccines may also Boost Immunity to Seasonal Coronaviruses and Influenza	Vennila Gopal	Received

P-543	Prediction of transmission inhibition based on the antiviral effect of ensitrelvir and simulation of its impact on epidemics	Shogo Miyazawa	Received

P-0561	Reduction of post COVID-19 condition during the Omicron wave: results from the EuCARE POSTCOVID Study	Andrea Santoro	Received

P-0579	Investigating the impact of vaccination and reinfection dynamics on the XBB variant of SARS-CoV-2	PRISCILA TRINDADE	Received

P-603	Post-acute sequalae of COVID-19 three to twelve months after infection: Delta versus Omicron	Siméon de Bruijn	Received

P-0605	Cerebrospinal fluid adenosine deaminase levels are non-discriminatory for the diagnosis of tuberculous meningitis in moderate TB incidence Singapore	Nicholas Ngiam	Received

P-0610	Multicentre in vitro susceptibility of nontuberculous mycobacteria to apramycin and amikacin: comparing MIC distributions and tentative epidemiological cutoffs	Minh-Vu Nguyen	Received

P-0611	Increased risk of all cause-mortality in active tuberculosis patients attributed to SARS-CoV-2 infection: atime-dependent survival analysis in Chile	Salvador Vargas-Garcia	Received

P-0615	Extrapulmonary nontuberculous mycobacteria infections: a ten-year review in a tertiary care hospital in Belgium	Eva Larranaga Lapique	Received

P-0636	Blood-based mRNA test for tuberculosis shows promising diagnostic accuracy	Seda Yerlikaya	Received

P-0651	Blood-based three-gene TB host response score is predictive of TB disease or 30-day mortality in hospitalised Ugandans with advanced HIV disease: a prospective cohort study	Jayne Ellis	Received

P-0668	A global perspective: the gene expression profile of tuberculosis disease among people living with HIV	Erwin Taguiam	Received

P-0675	Increase in cases of nontuberculous mycobacterial lymphadenitis presenting to Childrens Health Ireland: results of a 15-year retrospective case review	Cilian Ó Maoldomhnaigh	Received

P-676	Dynamic PET facilitated development of antibiotic regimens for tuberculous meningitis due to multidrug-resistant strains	Sanjay Jain	Received

P-678	Comparison of MIC results obtained with EUCAST BMD and MGIT for levofloxacin, moxifloxacin, D-cycloserine and linezolid	Manzour Hazbon	Received

P-0698	Adjunctive host-directed therapy to improve tuberculosis treatment outcomes: a systematic review	Gemma Skellern	Received

P-0708	An individual-level pooled analysis of pyrazinamide toxicity and weight-based dosing in pulmonary tuberculosis in adults	Navaneeth Narayanan	Received

P-723	The diagnosis, management and outcome of bone and joint tuberculosis infections in UK adults	Charlotte Hall	Received

P-0756	Infective endocarditis and discovertebral infections in older adults: complications and functional decline	Elise CASSAND	Received

P-0761	Community-acquired Staphylococcus aureus bacteraemia among people who inject drugs: a national cohort study in England, 2017-2020	Emma McGuire	Received

P-0769	Ceftobiprole is safe and efficacious in treating renal impaired patients with complicated Staphylococcus aureus bacteraemia (SAB), including those on dialysis: results from the ERADICATE Phase 3 study	Juana Perdomo-Guiraudet	Received

P-0771	An analysis of baseline conditions or complications of S. aureus bacteraemia from a double-blind, randomised Phase 3 study (ERADICATE) comparing ceftobiprole vs daptomycin	Juana Perdomo-Guiraudet	Received

P-0774	Comparison of ceftobiprole versus daptomycin for time to S. aureus bloodstream clearance in the recent double-blind randomised Phase 3 study (ERADICATE)	Juana Perdomo-Guiraudet	Received

P-0779	Epidemiology of bloodstream infections caused by extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae in Switzerland, 2015-2022: secular trends and association with the COVID-19 pandemic	Lauro Damonti	Received

P-0792	A hidden factor to healthcare-associated bloodstream infections: collection and technique of blood culture sampling	Guan-Jhou CHEN	Received

P-0816	Impact of evidence-based quality-of-care processes from clinical trial (CAMERA2) participation on methicillin-resistant c bacteraemia outcomes: an international, multicentre, retrospective study	I. Russel Lee	Received

P-0820	Approach to febrile neutropenia in Belgian hospitals	Yuri Charles Julia Vanbiervliet	Received

P-0830	The excess burden of antibiotic-resistant bloodstream infections among hospital patients: evidence from a retrospective cohort study in Chile, 2018-2022	Kasim Allel	Received

P-0834	Evaluation of outpatient parenteral antimicrobial therapy (OPAT) for infective endocarditis patients in a Belgian tertiary care centre	Helena Cornelia Van Den Hout	Received

P-0841	Bacteremia in Denmark from 2010-2022: A population based nationwide cohort study	Ram Benny Dessau	Received

P-0842	Partnership with a commercial bloodstream infection service team significantly improves blood culture volumes in one Spanish hospital emergency department	Lauren Cooper	Received

P-0855	Carbapenem combination therapy versus standard of care for persistent methicillin-susceptible Staphylococcus aureus bacteremia and endocarditis	Sunish Shah	Received

P-0864	Factors associated with treatment failure of Stenotrophomonas maltophilia bloodstream infections from a single-centre study	Sunish Shah	Received

P-0870	Staphylococcus aureus bacteremia: a monocentric, retrospective study comparing geriatric to non-geriatric patients	Sami Serraj	Received

P-0886	Patient outcomes of MBL-producing CRE infections: interim results from a retrospective observational study in two centres from the Kingdom of Saudi Arabia	Maria Gheorghe	Received

P-0917	Mortality impacts of inappropriate empirical antibiotic therapy in patients with bloodstream infections in Chile: a retrospective cohort study	Kasim Allel	Received

P-0921	Community and hospital-acquired Gram-negative bloodstream infections in non-ICU patients	Maria Kyziroglou	Received

P-0925	Bloodstream infections in allogeneic hematopoietic cell recipients: trends of incidence, susceptibility and risk factors for multidrug resistance	Sara Fernandes	Received

P-0940	Standard deviation of the monocyte distribution width as a prognostic indicator of death in septic patients	DIMITRIOS THEODORIDIS	Received

P-0967	Linezolid or daptomycin as alternative to vancomycin for the treatment of vancomycin-susceptible Enterococcus faecium bloodstream infection	Kevin Bouiller	Received

P-0970	Klebsiella spp. bacteraemia surveillance-collaborative strategies required to reduce the risk of infection	Nabeela Mughal	Received

P-0974	Epidemiological analysis of Legionella pneumonia in Japan: a national inpatient database study	Satoshi Kutsuna	Received

P-0975	Analysis of the effectiveness of combination antimicrobial therapy for Legionella pmeumonia: a nationwide inpatient database study	Satoshi Kutsuna	Received

P-1013	Adherence to antimicrobial guidelines for the treatment of Legionnaires disease in Switzerland: data from the SwissLEGIO multicentre study	Melina Bigler	Received

P-1027	Oral delivery of a cholera toxin-binding protein protects against diarrhoea in experimental cholera	Marcus Petersson	Received

P-1050	Performance evaluation of an expanded PCR panel for uropathogen identification in urinary tract infections compared to standard urine culture	Jelena Feenstra	Received

P-1051	Prognostic model for mortality assessment in patients with cirrhotic liver and infected ascites	Silvia Würstle	Received

P-1056	Prevalence of antimicrobial-resistant Mycoplasma genitalium among men who have sex with men: a systematic review and meta-analysis	Michael Sciaudone	Received

P-1064	Efficacy of linezolid in enterococcal urinary tract infection: a multicentre study	Kevin Bouiller	Received

P-1069	Unmasking colistin therapy for urinary tract infections due to multidrug-resistant bacteria: experience at a tertiary academic medical centre	Atheer Aldairem	Received

P-1071	Assessing the within-patient and within-household diversity of V. cholerae in a cholera endemic area	Aline Cuénod	Received

P-1072	Pyogenic liver abscess in elderly patients: predictive factors of unfavorable outcome	Ioannis Bourdalis	Received

P-1083	Evaluation of the vivalytic one analyser for detecting uropathogenic bacteria and antimicrobial resistances in urines samples of urological patients	Jessica Hartmann	Received

P-1088	Thomasclavelia ramosa is a specific signature of hepatocellular carcinoma among patients with alcohol-related liver disease: a culturomics and metagenomics case-control study	Reham Magdy Wasfy	Received

P-1090	Three-arm comparison of fidaxomicin monotherapy, fidaxomicin plus bezlotoxumab, and vancomycin plus bezlotoxumab on 90-day C. difficile clinical success	Madison Salam	Received

P-1095	ChiA: a major player in the virulence of Crohns disease-associated adherent and invasive Escherichia coli (AIEC)	Margot FARGEAS	Received

P-1107	Assessing the role of healthcare-seeking behaviours in the development of small-area health inequalities in EHR data using complex systems science methods	Brittany Lauren Morgan Bustamante	Received

P-1120	Safety and efficacy of tedizolid phosphate versus comparators in patients 12 years of age with acute bacterial skin and skin structure infections (ABSSSI)	Pamela Sears	Received

P-1142	Functional prognosis of older adults with tetanus: a single-centre retrospective study	Takeru Yamamoto	Received

P-1166	Burden of Lyme disease (BOLD) study: manifestations of clinically diagnosed Lyme borreliosis in six European countries	Kate Halsby	Received

P-1172	Leptospirosis and tularemia in a rural mountain valley in Switzerland and Italy	Flavio Bruni	Received

P-1183	Ruminants as potential reservoir for the emerging Shiga toxin-producing Escherichia coli O113:H4?	Denis Piérard	Received

P-1194	Incidence of lyme carditis and lyme carditis as a cause of permanent pacemaker implantation: a registry-based study	Sanna Avellan	Received

P-1245	Nocardiosis and poor prognostic factors: retrospective observational study	Carolina Monteiro	Received

P-1246	Origins of Bacillus subtilis strains isolated from blood cultures: insights from a single-centre retrospective study on traditional Japanese fermented soybeans Natto	Ryuichi Minoda Sada	Received

P-1250	Resistome diversity in coagulase-negative staphylococci from nostrils of healthy humans in La Rioja (Spain): genomic analysis of MDR-S. epidermidis and S. haemolyticus strains	Idris Nasir Abdullahi	Received

P-1251	Unveiling the potency of combined fosfomycin and meropenem against methicillin-resistant Staphylococcus aureus (MRSA) using the hollow-fiber infection model	Tetsuo Yamaguchi	Received

P-1282	Antimicrobial susceptibilities of toxin producing Corynebacterium diphtheriae and Corynebacterium ulcerans in Belgium	Zan Janssen	Received

P-1405	Co-existence of extended-spectrum &946;-lactamases and carbapenemases in neonatal Klebsiella pneumoniae isolates from a childrens specialized hospital in Cairo, Egypt	Marwa Abou-Galiel	Received

P-1449	Aztreonam-avibactam resistance is lower than cefiderocol resistance in recent carbapenemase-positive Enterobacterales from the German National Reference Centre (NRC) for multidrug-resistant Gram-negative bacteria	Agnes Anders	Received

P-1470	Epidemiologic, clinical profile and antibiotic sensitivity and resistance pattern of melioidosis at Southern Isabela Medical Centre, Santiago City, Philippines	Maria Jonelyn Mendoza-Colobong	Received

P-1483	Antimicrobial resistance of Shigella spp. in south Australia and its detection using whole genome sequencing	Helena Torpy	Received

P-1491	The global burden of infections caused by metallo-&946;-lactamase- producing carbapenem-resistant Enterobacterales: results of a targeted literature review	Maria Gheorghe	Received

P-1520	In vitro activity of funobactam (XNW4107) combined with imipenem against Gram-negative isolates collected in 2021	Jianguo Li	Received

P-1554	Comparison of two commercial broth microdilution panels for AST of multidrug-resistant Gram-negative bacteria	Antoine Aupaix	Received

P-1557	Development and evaluation of gradient strip-based synergy testing methods to determine susceptibility of carbapenem-resistant Gram-negative organisms to the aztreonam (ATM) and ceftazidime-avibactam (CZA) combination	Carmila Manuel	Received

P-1558	Rapid antimicrobial susceptibility testing by SdFFF directly from positive blood cultures	Linda TLILI	Received

P-1563	Minimal inhibitory concentrations (MICs) of tigecycline correlate strongly with those of omadacycline	Vinicius Calado Nogueira de Moura	Received

P-1564	Validation of aztreonam-avibactam MIC antimicrobial susceptibility test for MicroScan dried Gram-negative MIC panels from a multicenter assessment of Enterobacterales, Pseudomonas species, and Stenotrophomonas maltophilia	Christine Hastey	Received

P-1568	Performance of a novel holographic imaging system for rapid susceptibility testing directly from Gram-negative positive blood cultures	Lawrence Mertz	Received

P-1596	Analytical and clinical performance of a rapid AST system directly from positive blood cultures: results of a real-life diagnostic clinical trial in Madrid, Spain	Rota Louis	Received

P-1614	Evaluation of disk diffusion breakpoints for Aerococcus spp. using CLSI methods	Richard Maynard	Received

P-1615	Fine tuning polymyxin B combinations: tackling the growing threat of pan-drug resistant Klebsiella pneumoniae	Jan Naseer Kaur	Received

P-1620	Prospects for using MICs assessed under clinically relevant conditions to predict the development of antibiotic resistance: a study with meropenem and Klebsiella pneumoniae	Stephen Zinner	Received

P-1630	Inoculum effect of meropenem and meropenem/avibactam with Klebsiella pneumoniae: can MIC at high inoculum predict MPC?	Stephen Zinner	Received

P-1631	Comparison of commercial methods for evaluating susceptibility to cefiderocol	Edoardo Carretto	Received

P-1653	Utilisation of the breakpoints from the clinical and laboratory standards institute and the European committee on antimicrobial susceptibility testing at the quality control programme of the Spanish Society of Infectious Diseases and Clinical Microbiology	Enrique Ruiz de Gopegui Bordes	Received

P-1656	Divergent genetic landscapes drive lower levels of AmpC induction and stable de-repression in Serratia marcescens compared to Enterobacter cloacae	Jacob Lazarus	Received

P-1671	In vivo evolution of a novel KPC-144 variant conferring ceftazidime/avibactam resistance in ST11 carbapenem-resistant Klebsiella pneumoniae	Ping Yang	Received

P-1716	Comparative genomic analysis reveals the emergence of ST-2096 Klebsiella pneumoniae strains associated with the high transmissibility of blaOXA-232 in Oman	Arwa AlRujaibi	Received

P-1744	Adaptation of an antibiotic disc-based assay for improved detection of carbapenemases in Enterobacterales	Meg Jago	Received

P-1747	Evaluation of blood culture identification and antimicrobial resistance instrumentation for detection of antimicrobial resistance markers	Richard Maynard	Received

P-1773	Refined algorithm for detection of OXA-48-like carbapenemase producing Enterobacterales	Peter Keller	Received

P-1796	Evaluation of a commercial test for the rapid detection of third-generation cephalosporins resistance in Enterobacterales on early culture of positive blood cultures	Mehdi Bonnet	Received

P-1812	Resistance to novel &946;-lactam/&946;-lactamase inhibitors among carbapenem-resistant Pseudomonas aeruginosa and clinical implications in the prospective observational Pseudomonas (POP) study	Lee Gottesdiener	Received

P-1815	The changing epidemiology and long-term outcomes of patients with CRE infections	Ryan Shields	Received

P-1822	Multidrug-resistant organism bloodstream infections in solid organ transplant recipients and impact on mortality: a systematic review	Alice Liu	Received

P-1826	Impact of colistin MIC on outcomes: results from the OVERCOME trial comparing colistin monotherapy and colistin meropenem combination therapy	Jason Pogue	Received

P-1829	Black females hospitalised in the United States have worse outcomes after carbapenem-resistant Enterobacterales (CRE) bloodstream infection (BSI)	Felicia Ruffin	Received

P-1836	Excess mortality due to antimicrobial resistance in bacteraemias among cancer patients in Oxford and Oslo, 2008-2018	Anders S. Danielsen	Received

P-1843	Prevalence of antimicrobial resistance in patients with cancer in the outpatient setting: a multicentre analysis	Diane Flayhart	Received

P-1861	Increased abundance of ESBL producing Enterobacterales in municipal wastewater receiving hospital effluent during and after the COVID-19 pandemic	Lisandra Aguilar Bultet	Received

P-1864	The overlooked pandemic in the shadow of COVID-19: antimicrobial use and resistance data, a Romanian single-centre study	AGNES CSISZER	Received

P-1896	The veterinary hospital as a cross-infection hub of multidrug resistant bacteria	Tal Zilberman Daniels	Received

P-1898	Urban and rural free-ranging hedgehogs as sentinels of environmental extended-spectrum beta-lactamase producing enterobacterales	Tal Zilberman Daniels	Received

P-1904	Antimicrobial resistance of Mammaliicoccus species and staphylococci other than Staphylococcus aureus isolated from retail beef in KwaZulu Natal, South Africa	Evelyn Madoroba	Received

P-1908	Evidence-based policy for mitigating AMR in Lao PDR: an intervention-implementation research approach	Somphou Sayasone	Received

P-1921	High levels of antibiotic resistance: latest insights from WHOs GLASS surveillance system	Olga Tosas Auguet	Received

P-1932	Evaluation of a novel chromogenic culture medium for the detection and enumeration of Pseudomonas aeruginosa	Jose Degrossi	Received

P-1933	Evaluation of the analytical and clinical performance of a new diagnostic test for the detection of Campylobacter antigens in stool specimen	JUERGEN Becker	Received

P-1946	Evaluation of a 16 hour incubation for urine culture using wasp/wasplab imaging analysis	Mark Gaskin	Received

P-1955	Performance of a novel chromogenic agar for primary isolation of pathogenic beta-hemolytic streptococci from throat swabs	Abdulrahman Almodahka	Received

P-1964	Detection of diphtheria toxin production by Elek test: interlaboratory proficiency testing among three laboratories in three different countries	Anja Berger	Received

P-1965	Improved Performance in Diagnosis of Lyme Disease Utilizing a Novel Multiplexed Modified Two-Tier Test when Compared with the Standard Two-Tier Test	Thomas R. Fritsche	Received

P-1981	LEAN optimisation with two track integrated InoqulAs	Mariska Okkema-van der Lei	Received

P-1992	Performance and workflow comparison between two MALDI TOF MS systems in microbiology routine laboratory settings	Ulrich Eigner	Received

P-2018	Duplex Salmonella spp. qPCR for screening of poultry environmental samples	Durda Slavic	Received

P-2021	Filmarray syndromic diagnostics strengthens clinical outcomes, biosecurity and response in eight small island states	John Lee	Received

P-2026	T2 magnetic resonance technology identifies 3.55 times more on-panel Candida species compared to conventional blood culture	Oscar Guzman	Received

P-2046	Assessment of various transport media for compatibility with a novel molecular point-of-care system for respiratory viruses	JUERGEN Becker	Received

P-2055	A commercial molecular diagnostic test: clinical case series of the top six bloodstream infection and sepsis causing bacteria	Erin Meyers	Received

P-2058	Evaluation of a commercial multiplex PCR assay as a routine screening method for the detection of stool pathogens	Sarona Lengana	Received

P-2070	Comparison of the QIAstat-Dx and the BioFire for the detection of viral and bacterial respiratory tract pathogens	Karoline Leuzinger	Received

P-2088	Quantitative PCR: a novel clinical tool for patients with bloodstream infections	Erin Meyers	Received

P-2092	Evaluation of clinical performance and usability of a new automatic assay for gastrointestinal syndromic testing	Ulrich Eigner	Received

P-2114	Novel molecular assays for detection of the opportunistic pathogen Kalamiella piersonii.	Louise O Connor	Received

P-2122	Evaluation and proof of concept study for timely antimicrobial resistant organisms tacking (TAROT)	Kotaro Aoki	Received

P-2128	Investigation of multidrug resistant Acinetobacter baumannii using IR Biotyper, a Fourier transform infrared spectroscopy system	Felipe Tuon	Received

P-2169	Hyper-transmissible Klebsiella pneumoniae carbapenemase (KPC): unravelling multi-species transmission within a single patient using whole genome sequencing	Xena Li	Received

P-2186	Antibiotic treatment delayed gut microbiome recovery in children with watery diarrhoea	The Hao Chung	Received

P-2227	Antimicrobial resistance and pathogens detection in clinical samples through enrichment panels as a tool to detect infectious diseases in a timely manner	Robert Schlaberg	Received

P-2228	Quality control (QC) metrics for hybrid capture-based NGS enrichment workflows	Robert Schlaberg	Received

P-2232	Genetic diversity and virulence factors in Escherichia coli: a comparative study between neonatal sepsis, adults and environmental sources	lucia barcellini	Received

P-2247	Breath biopsy reveals promising VOC biomarkers for early detection and monitoring of acute pulmonary exacerbations in people with cystic fibrosis	Lucy Godbeer	Received

P-2248	The association of host signature based on TRAIL, IP-10, and CRP with paediatric pneumonia	Sriram Ramgopal	Received

P-2266	High level of performance of two anti-Staphylococcus aureus phages on clinical strains (PST CE-IVD)	Rafael Gomes Von Borowski	Received

P-2268	Determination of the PK/PD driver for the LepB inhibitor, GDC-5780, a novel gram-negative antibiotic against Enterobacteriaceae infections	Min Xu	Received

P-2302	Post-&946;-lactamase-inhibitor effect of nacubactam in combination with aztreonam and cefepime on ESBL, AmpC, KPC, or OXA-48-producing Enterobacterales	Hayato Okade	Received

P-2313	In vitro potency of ceftibuten combinations with xeruborbactam, ledaborbactam or avibactam against recent European isolates of Enterobacterales	Uri Rodny	Received

P-2315	Determination of the PK/PD driver for the LepB inhibitor, GDC-0829, a novel broad-spectrum antibiotic against Gram-negative bacterial infections	Min Xu	Received

P-2325	A platform for screening of inhibitors of bacterial antibiotic resistance mechanisms	Jitka Viktorová	Received

P-2336	Low frequency of spontaneous resistance to LepB inhibitors, GDC-5780 and GDC-0829, in target Gram-negative bacterial species	Hany Girgis	Received

P-2339	In vivo evaluation of CZ-02188: PK and in vivo efficacy for a new class of antibacterial agent	Chad Testa	Received

P-2344	Combination of minocycline and ciprofloxacin enhances the inhibitory effect of TNF alpha production in LPS-stimulated THP-1 cells	Ippei Sakamaki	Received

P-2373	Rational in vitro design of a two-phage cocktail against a contemporary A. baumannii strain recovered from a burned patient at CHUV	Hugues de Villiers de la Noue	Received

P-2379	Mechanism of in vitro resistance to zosurabalpin (RG6006) in Acinetobacter baumannii	Andrej Trauner	Received

P-2380	Cloxacillins efficacy against Cutibacterium acnes: MIC evaluation and utility of Etest	Alkmini Angelopoulou	Received

P-2383	Metformins double duty: from antidiabetic hero to antibiotic dilemma	Lina Maarouf	Received

P-2417	Pharmacodynamics of fosfomycin in combination with meropenem: impact on the size of the fosfomycin pharmacodynamic index for Klebsiella pneumoniae	Marie Attwood	Received

P-2418	Therapeutic drug monitoring of ceftazidime/avibactam supports continuous infusion administration: a retrospective analysis of pharmacological, microbiological, and clinical outcomes	Sara Ferin	Received

P-2419	Pharmacokinetics and safety in ICU patients and healthy participants following single dose administration of zosurabalpin (RG6006), a novel pathogen-specific antibiotic for the treatment of serious Acinetobacter infections	Emmanuelle Cottreel	Received

P-2428	Pharmacodynamic index driver of NOSO-502: conclusions from in vivo and in vitro studies	Marie Attwood	Received

P-2446	Pharmacokinetics of ceftazidime/avibactam in bile fluid: an in vivo study	Lars Palmowski	Received

P-2451	A PHASE I FIRST-IN-HUMAN STUDY IN HEALTHY VOLUNTEERS WITH INTRAVENOUSLY ADMINISTERED OMN6, A NOVEL ANTIMICROBIAL PEPTIDE TARGETING ACINETOBACTER BAUMANNII	Niv Bachnoff	Received

P-2458	Evaluation of the stability of ceftazidime/avibactam in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy utilising a national stability protocol framework	Fekade Sime	Received

P-2510	Pharmacokinetics, safety, and tolerability of funobactam alone or in combination with imipenem/cilastati in healthy subjects	Jianguo Li	Received

P-2522	Outcomes at test of cure by baseline pathogen and cefepime-taniborbactam or meropenem MIC in the Phase 3 CERTAIN-1 study of patients with complicated urinary tract infection (cUTI)	Greg Moeck	Received

P-2531	Gepotidacin and nitrofurantoin efficacy by baseline uropathogen phenotypes and genotypes recovered from EAGLE-2/EAGLE-3 clinical trials for uncomplicated urinary tract infections	Nicole Scangarella-Oman	Received

P-2532	In vitro activity of gepotidacin against baseline uropathogenic phenotypes and genotypes recovered from EAGLE-2/EAGLE-3 clinical trials for uncomplicated urinary tract infections	Nicole Scangarella-Oman	Received

P-2533	Colistin/meropenem: the impact of synergy on outcomes in the OVERCOME trial	Mariya Huralska	Received

P-2536	Efficacy of ceftazidime-avibactam versus ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the United States (CACTUS) among immunocompromised patients	Ryan Shields	Received

P-2550	A Phase 1 study of the safety, tolerability, and pharmacokinetics of the beta-lactamase inhibitor xeruborbactam (XER) administered as the isobutyryloxymethyl oral prodrug to healthy adult subjects	David Griffith	Received

P-2555	Successful intervention in intensive care unit (ICU) of a private hospital in Rio de Janeiro: decreasing MDR bugs and keeping the patients safety	Wania Vasconcelos De Freitas	Received

P-2556	Hospital-based antimicrobial stewardship in Denmark, Greenland, and the Faroe Islands: current landscape and barriers	Christian Kraef	Received

P-2564	Successful implementation of an antimicrobial stewardship program in an oncology center in Lima, Peru	Carlos Seas	Received

P-2572	A multi-centre quantitative and qualitative evaluation following removal of a linezolid formulary restriction	Thomas Liu	Received

P-2573	Oral doxycycline for bacterial cystitis: an underutilised tool for antimicrobial stewardship programs	Emily Oneill	Received

P-2574	Assessment of a rapid diagnostic assay and antimicrobial stewardship intervention on treatment of gram-negative bacteremia	Julian Ventres	Received

P-2581	Factors associated with antibiotic use in long-term care facilities: a systematic review of quantitative studies	AURELIE BOCQUIER	Received

P-2582	Achievement of an optimal vancomycin plasma concentration according to different loading dose regimens, a prospective observational multicentre cohort study, VANCOCINEMA	Adrien GALY	Received

P-2585	Impact of proactive antimicrobial stewardship (AS) intervention with a computerised microbiological alert system in patients with bloodstream infections (BSI): a pre-post intervention study	Arianna Di Marcello	Received

P-2597	National surveillance of antibiotic use among dentists in Japan from 2015 to 2021 using the national database of health insurance claims and specific health checkups of Japan	Masahiro Ishikane	Received

P-2600	Pharmacist-led optimisation of discharge antibiotic therapy duration in the emergency department	Joel Zapata	Received

P-2602	Promoting real-world evidence use in antimicrobial stewardship in Latin America	Juan Carlos Garcia Betancur	Received

P-2603	Effect of an antibiotic stewardship intervention on provider prescribing behavior for acute respiratory infections	Larissa May	Received

P-2618	The first national audit of antifungal prescribing quality in Australia	Anna Khanina	Received

P-2619	Improving patient outcomes by addressing access disparities to develop quality antimicrobial stewardship programmes	Jacqueline Sneddon	Received

P-2625	Antibiotic prescription appropriateness in directing stewardship interventions and benchmarking	Liliana Dias	Received

P-2629	Measuring the impact of improved diagnostics on antimicrobial stewardship in respiratory tract infection (MIDAS-RTI Study)	Alexandria Chung	Received

P-2652	Mapping methods and metrics for assessing antibiotic use in primary care	Martina Maria Raffaella Escher	Received

P-2688	Patient-focused training in outpatient parenteral antimicrobial therapy (OPAT) results in significant increases in self-administration	Imogen Kemp	Received

P-2697	Engaging the patients and prescribers of tomorrow to address antimicrobial resistance	Christopher Little	Received

P-2700	Point-of-care tests for acute respiratory infections need comprehensive implementation packages to support use in primary care	Sibyl Anthierens	Received

P-2703	Adherence of quality indicators for appropriate antibiotic use in the emergency department (ED)	Garreta Fontelles Gemma	Received

P-2709	Uptake of OpenWHO massive open online courses on antimicrobial stewardship	Deborah Tong	Received

P-2716	Facilitating safer fluoroquinolone prescribing using formalised risk-assessment	Sandra Lauhoff	Received

P-2731	Incidence of serotonin syndrome caused by tedizolid and concomitant serotonergic agents	Sunish Shah	Received

P-2732	Intravenous push vs intermittent infusion beta-lactams in paediatrics: safety and time to administration	Kassandra Marsh	Received

P-2760	Mycological trends (1999-2019) in patients treated for postoperative peritonitis	Philippe Montravers	Received

P-2762	Point prevalence study of Candida auris in a tertiary hospital in Crete, Greece	Petros Ioannou	Received

P-2767	The state of laboratory mycology in France in 2023: a survey from the European Confederation of Medical Mycology (ECMM), International Society for Human and Animal Mycology (ISHAM) and French Society of Medical Mycology (SFMM)	Francoise Botterel	Received

P-2794	How paediatric epidemiology and outcome of yeast fungemia differ from adults	Fanny Alby-Laurent	Received

P-2831	Immune profile in Covid-19 associated pulmonary aspergillosis: The CYTOCAPA Study	Olivier Mascle	Received

P-2840	Gastrointestinal mucormycosis: an analysis of 319 adults from the FungiScope registry and literature	Ertan Sal	Received

P-2855	Point-of-care testing for peritoneal and serum 1.3 beta-D-glucan to rule out intra-abdominal candidiasis in critically ill patients	Emmanuel NOVY	Received

P-2867	Rapid and High Throughput Automated Candida auris PCR Assay for Clinical Laboratory	Yiu Shun, Terrence Kung	Received

P-2874	Verification, analytical sensitivity, cost-effectiveness, and comparison of four Candida auris screening methods	Xena Li	Received

P-2898	Pentraxin 3 in onco-haematological patients: a potential biomarker for invasive fusariosis and aspergillosis	Larissa Simão Gandolpho	Received

P-2923	In vitro activity of olorofim against the agents of the endemic mycoses	Corinne Pinder	Received

P-2924	In vitro activity of olorofim against Scedosporium species, Lomentospora prolificans and Scopulariopsis species	Corinne Pinder	Received

P-2939	Inoculum density has an impact on SF001 fungicidal activity against Candida albicans	David Hufnagel	Received

P-2953	Amino-acid substitutions in CYP51A protein from Purpureocillium lilacinum likely to be associated with itraconazole resistance	Lorra Monpierre	Received

P-2984	Efficacy and safety of L-AmB-containing treatment on paediatric IFD patients previously exposed to broad spectrum antifungal agents	Beiqun Chen	Received

P-2989	Revisiting amphotericin B prophylaxis in patients with haematology malignancies	Gajaani Kuganarul	Received

P-2990	SF001, a novel micellar polyene, demonstrates a prolonged post-antifungal effect in vitro against yeast	David Hufnagel	Received

P-3015	Fungal BET protein Bdf1 shows promise as a potential antifungal drug target in Candida spp.	Carlo Petosa	Received

P-3016	Rodent-adapted Cryptosporidium infections in humans: seven new cases and review of the literature	Christen Rune Stensvold	Received

P-3033	Visceral leishmaniasis resurgence after COVID-19 pandemic. Data from Regional Surveillance System of the Lazio Region (Italy)	Martina Spaziante	Received

P-3068	Evolving trends of molecular subtyping and macrolide resistance of Treponema pallidum in British Columbia, Canada: a ten years review	Muhammad Morshed	Received

P-3073	Acanthamoeba castellanii prefers lipids as food, offering new possibilities for treatment	Maarten Sarink	Received

P-3074	Visceral leishmaniasis by L. infantum in immunosupressed patients	Juan San Martín	Received

P-3090	Imported Plasmodium vivax Cases Among Newly Arrived Migrants in New York City	Maria Alyssa Policarpio	Received

P-3099	S. stercoralis infections in a Tropical Medicine Clinic - a 5 year retrospective review	Maria Alyssa Policarpio	Received

P-3100	Sexual and reproductive health of female asylum seekers seen by RESPOND, a UK integrated refugee health screening programme	Rebecca Ryan	Received

P-3105	The malaria mantra mislaid: new insights from a retrospective analysis of malaria cases at a UK south coast centre	Daisy Woolham	Received

P-3107	Views and experiences of catch-up vaccination among adult migrants in the UK: an in-depth interview study	Anna Deal	Received

P-3112	Tick-borne encephalitis seroprevalence in Northern Italy: a cross-sectional study on a randomly ed population	Rebeka Skurti	Received

P-3121	Antimicrobial resistant enterococci in semi-intensive and free-range broiler farms in Uganda	Linnet Atieno Ochieng	Received

P-3141	Climate change negatively impacts AMR	Srishti Goel	Received

P-3143	Factors that affect the timely diagnosis and treatment of neutropenic fever in Ugandan patients with cancer and HIV: A process mapping study	Elizabeth Gulleen	Received

P-3145	The experience of genital ulcer disease, barriers to treatment and acceptability of sexually transmitted infection diagnostics in Harare, Zimbabwe	Catrin Thomas	Received

P-3154	Infectious disease profile in the Embera Dóbida, indigenous tribe of Colombian Pacific Coast: descriptive cross-sectional study	Pedro Hernandez	Received

P-3156	High prevalence of antimicrobial resistance in bacterial isolates from clinical specimens in Timor-Leste	Tessa Oakley	Received

P-3184	Sonication fluid culture shows little benefit compared with optimised periprosthetic tissue sample culture for diagnosis of periprosthetic hip infections	Nora Koenemann	Received

P-3186	Suppressive antimicrobial therapy for prosthetic joint infection	Craig Aboltins	Received

P-3191	Clinical experience with intravenous (IV) fosfomycin for treatment of complex bone and implant-associated infections: prospective cohort	Svetlana Karbysheva	Received

P-3202	Optimising prophylactic antibiotic use among surgery patients in Ethiopian hospitals	Niranjan Konduri	Received

P-3211	Optimising antibiotic ion in Fourniers gangrene: a rationalised approach in the South East of Scotland	Simon Dewar	Received

P-3216	A multi-faceted, surgically led quality improvement initiative produces positive change in surgical antibiotic prophylaxis practices	Katie Giblin	Received

P-3223	Risk factors on multiple drug-resistant organisms infection in patients with nosocomial pneumonia and their prognosis assessment: a nationwide multi-centre, large population, retrospective nested case-control study	Zhenchao Wu	Received

P-3233	The clinical characteristics and bacterial genomics of HAP caused by Acinetobacter baumannii	Zhenchao Wu	Received

P-3247	Pathogenic microbial contamination of handwashing sinks changes over time following installation	Itaru Nakamura	Received

P-3257	Rapid MRSA/MSSA surveillance: insights from a six-years dual molecular-cultural approach	Valeria Cento	Received

P-3281	Transmission of multidrug-resistant organisms during physical and occupational therapy appointments at three VA CLCs	Kristen Gibson	Received

P-3283	Epidemiology of MDROs Across 3 Veterans Affairs Nursing Homes and MDRO Transmission During Interactive Visits	Lona Mody	Received

P-3287	Investigation of the environmental presence of Pseudomonas aeruginosa to facilitate sequence analysis and determine a possible cause of bloodstream infection	Katherine Dever	Received

P-3299	Assessment of locally-implemented vs centrally-implemented mandatory reporting of healthcare-associated infections in England	Phuong Quan	Received

P-3307	Time-saving water monitoring -qPCR-based detection of up to 15 Legionella cells per mL within 4 hours	Peter Keller	Received

P-3332	Significant and sustained decline in catheter-associated urinary tract infections rate following implementation of a multifaceted interdisciplinary infection prevention programme	Avish Nagpal	Received

P-3339	Whole-genome sequencing revealed multiple undetected SARS-CoV-2 outbreaks in a university hospital in Norway	Kirsten Gravningen	Received

P-3346	Increasing incidence of Clostridium difficile (CDI) infection in admitted patients in the post covid era: epidemiological data	Dimitrios Kouroupis	Received

P-3348	Outcome of Clostridium difficile infection (CDI) in admitted patients; association with epidemiological and clinical parameters	Dimitrios Kouroupis	Received

P-3359	Exploring the Mode of Transmission of community-acquired C.difficile from the concept of One Health	Sadako Yoshizawa	Received

P-3363	Cost-effectiveness analysis in the treatment of Clostridioides difficile infection in the Brazilian healthcare system and faecal transplant microbiote	Felipe Tuon	Received

P-3368	A hospital outbreak with methicillin-resistant Staphylococcus argenteus in the Netherlands, June 2023	Serena Slavenburg	Received

P-3375	Empiric treatment of healthcare-associated central nervous system infections in Denmark: do we need carbapenems?	Christian Kraef	Received

P-3377	Use of bezlotoxumab for the prevention of Clostridioides difficile infections within the German health care system: an observational post-authorization study (BODEGA Study)	Katharina Giesbrecht	Received

P-3384	High risk of recurrent Clostridioides difficile infection after previous episodes, regardless of treatment or number of recurrences	Mns Stefansson	Received

P-3396	Implementing nanopore whole-genome sequencing in C. difficile surveillance and outbreak investigation	Anita Blomfeldt	Received

P-3400	Clostridioides difficile-associated infections: a gap in the Swiss surveillance of hospital-acquired infections	andreas widmer	Received

P-3403	Early developability assessment of a single-domain antibody construct for gastrointestinal neutralisation of Clostridium difficile toxins	Everardo Rodriguez Rodriguez	Received

P-3431	Nanoparticle-impregnated textiles as a promising tool to reduce incidence of healthcare-associated infections in the intensive care unit: an interrupted time-series study	Diego Falci	Received

P-3434	Semi-continuous disinfection of sinks with UVC on a haematology-oncology department for prevention of nosocomial infection	Wil van der Zwet	Received

P-3445	Alcohol-based hand rubs meet EN 1500 requirements in 15 seconds	Christoph Senges	Received

P-3464	Factors influencing healthcare workers compliance with infection prevention and control measures in acute care settings during the COVID-19 pandemic in Canada	Nicole Robertson	Received

P-3483	ST218 Klebsiella pneumoniae became a high-risk clone for multidrug resistance and hypervirulence	Ping Yang	Received

P-3496	Cyclophilin AIL09810.1 from Stenotrophomonas maltophilia has a PPIase activity and could potentially be inhibited by non-peptide small-molecule cyclophilin inhibitors	Francoise Botterel	Received

P-3537	Urinary tract microbiome of asymptomatic individuals with spinal cord injury	Ezra Valido	Received

P-3540	Multi-kingdom oral microbiome analysis identifies biomarkers of early-onset cryptogenic ischemic stroke	Muhammed Manzoor	Received

P-3546	Humanised serum concentrations of meropenem, meropenem-vaborbactam, and ceftazidime-avibactam against carbapenem-resistant Enterobacter cloacae	Thomas Lavoie	Received

P-3561	Dietary consumption of antibiotics can favour the colonization of antibiotic resistant Gram-negative pathogens (ARGNs) in an ex-vivo model of the human gut microbiome	Didier Hocquet	Received

P-3583	Staphylococcus aureus biofilm attachment strength correlated to zeta-potential charge	Thomas Lavoie	Received

P-3587	SdiA regulates biofilm maturation of Klebsiella pneumoniae in response to C6-HSL	Sergio Silva Bea	Received

P-3603	Are quaternary ammonium compounds effective against carbapenemase-producing microorganisms?	Elisabeth Presterl	Received

P-3629	In vitro biofilm formation by methicillin-resistant S. aureus in skin, blood, and bone/joint infections	Kevin Bouiller	Received

P-3630	CRISPRi-seq identifies genes enhancing phage lysin Cpl-1 susceptibility in S. pneumoniae	Hugues de Villiers de la Noue	Received

P-3639	Development of an antibacterial plus bacteriophage combination assays	Marie Attwood	Received

P-3683	Metabolomic perturbations dictate bacterial growth in the human bloodstream	Lovnish Thakur	Received

P-3728	Chimeric antigen receptor T cell post-infusion fever: infection profile, clinical parameters and biomarkers trends to assist antibiotic stewardship	Olivier Peyrony	Received

P-3771	Herpes simplex virus prophylaxis in adult patients undergoing haematopoietic stem cell transplantation	Atheer Aldairem	Received

P-3775	Real-world utilisation of maribavir for cytomegalovirus infection in transplant recipients	Kassandra Marsh	Received

P-3777	Infection risk in relapsed refractory multiple myeloma: The impact of BCMA-targeted bispecific antibody therapy	Jessica Little	Received

P-3786	Incidence of infections in patients with acute myeloid leukemia during remission induction chemotherapy: a monocentric retrospective analysis of 78 patients	Sabine Ehrlich	Received

P-3795	Hospitalisation status at the time of organ acceptance and its impact to bloodstream infections	Jacques Simkins	Received

P-3798	Defining the role of primary care in hepatitis B elimination in the UK	Jessica Carter	Received

P-3807	Myths and misinformation associated with vaccine incompleteness: a survey study	Lucas Kallás Silva	Received

P-3809	Investigating vaccine coverage in Timor-Leste in a population-representative serological survey	Paul Arkell	Received

P-3815	BNT162b2 vaccine is well tolerated and efficient in children with acute leukemia	Fanny Alby-Laurent	Received

P-3850	Immune effects of membrane vesicle on elimination of pneumococcal colonisation in the nasopharynx	Soichiro Kimura	Received

P-3858	Opsonic IgG2a and IgG2b monoclonal antibodies targeting HSP16.3 and peptidoglycan cell wall components recognise and effectively bind to clinical strains of Mycobacterium tuberculosis	Clara Sei	Received

P-3867	AIM impact on immune checkpoints in Mycobacterium avium infection	Chiaki Kajiwara	Received

P-3868	Accuracy of a host response test for diagnosis of bacterial and viral infections and prediction of illness severity	Oliver Liesenfeld	Received

P-3888	A potential biomarker in symptomatic West-Nile virus (WNV) infections: monocyte CD169 (mCD169) expression in peripheral blood	Crapis Massimo	Received

P-3895	SeptiCyte rapid, a new biomarker for the diagnosis of ventilator-associated pneumonia in polytrauma patients	Lisa Neutre	Received

P-3898	Graduate to scientist in UK microbiology: choosing the right path	Ashleigh Hale	Received

P-3902	What do we know about different stakeholders attitudes towards sharing participant-level biomedical data during and outside of pandemics? A measurement systematic review	Lauren Maxwell	Received

P-3907	Evaluation of multidisciplinary tutorials sessions about antibiotics in the third year of pharmacy studies, school of pharmacy, Angers, France	Audrey Taisne	Received

P-3922	How does ChatGPT respond to questions pertaining to vaccine hesitancy from the general public?	Nicholas Ngiam	Received

P-3923	ChatGPT as a tool to improve knowledge on sexually transmitted infections	Nicholas Ngiam	Received

P-3925	First steps in establishing EU/EEA level surveillance of bloodstream infections from electronic health records	Alexis Sentís	Received

P-3932	Health Catch-UP!: process evaluation and co-development of an implementation strategy for a migrant multi-disease screening and vaccination tool	Jessica Carter	Received

P-3940	Epidemiology of the national clinical infectious disease response service in Japan during 2014&8722;2023	Masahiro Ishikane	Received

P-3956	Rapid multiplex antigen testing and self-d symptom checkers as a tool to detect and manage respiratory disease on a university campus	John Mac Sharry	Received

P-3968	mHealth for point-of-care testing and self-reporting of an infectious disease: a systems developer perspective	John Mac Sharry	Received

P-3972	Clinical decision support of meropenem continuity in PICU using machine learning	Jaber Abdullah	Received

P-3974	Off-label indications and outcomes for watch and reserve antibiotics according to the WHO AWaRe classification: a real-time interactive computer-assisted one-year survey in a large tertiary care hospital in northern Italy	Livia Marletta	Received

P-3976	The Colombo dengue study: a successful collaboration between two countries for more inclusive research	Chaturaka Rodrigo	Received

P-3977	Evaluating social determinants of health (SDOH) in a diverse cohort initiating long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in NYC	Patricia Pagan Pirallo	Received

P-3978	An equitable strategy to recruit underserved populations into LAI-PrEP Care in NYC	Ofole Mgbako	Received

P-3989	Hepatitis B virus reactivation in a cancer patient with seronegative occult hepatitis B infection	Harrys A Torres	Received

P-3991	The utilisation of microbial cell-free DNA next-generation sequencing for the detection of human herpesvirus-8 in a quaternary care centre	Rebecca Berger	Received

P-3997	Dengue-induced haemophagocytic lymphohistiocytosis	Irene ODea	Received

P-4010	Occupational transmission of measles in the COVID-19 era	Gabriella De Carli	Received

P-4018	Severe adenovirus pneumonia in immunocompetent patients presenting as typical bacterial pneumonia	matthew Kennedy	Received

P-4026	The devastating triad: a rare case of Austrian syndrome following COVID-19 infection	Adrian Estepa	Received

P-4082	Community-acquired meningitis due to Pseudomonas aeruginosa (PA) in an immunocompetent patient: case report and literature review	Alina-Ioana Popa	Received

P-4110	Tigecycline-based regimens for complicated urinary tract infections caused by carbapenem-resistant Gram-negative bacteria: case series	Maria-Evelina Gorea	Received

P-4114	Mycobacterium abscessus complex pneumonia in two immunocompetent patients	Ana Fernandez	Received

P-4118	Unusual syphilis chronicles: unveiling skeletal involvement in two cases at an Italian STI clinic	Lorenzo Brando Lundgren	Received

P-4125	A mysterious chest pain	Enrico Patrese	Received

P-4130	Clinical dilemma: to treat or not to treat the mother in a case of early onset neonatal invasive Neisseria meningitidis serogroup Y infection	Conor Mulrooney	Received

P-4146	An illustrative case series of complex and challenging left ventricular assist device infections	Nim Wickramasinghe	Received

P-4159	Primary pyogenic ventriculitis caused by Neisseria meningitidis Serogroup Y	Gavin Francis Kelly	Received

P-4162	Mycoplasma hominis and two severe clinical presentations	Laura Huyveneers	Received

P-4178	Multifocal actinomycosis in a penicillin-allergic patient	Rebecca Ryan	Received

P-4180	Crossing the diagnostic gap	Abusalem Lana	Received

P-4190	Paracoccidioidomycosis with dramatic skin manifestations	Aliya Rehman	Received

P-4218	Cryptococcal meningitis in Timor-Leste: a case series	Lucia florenciana toto	Received

P-4220	Interdisciplinary and multimodal seamless cooperation successfully cured one case of hemoptysis pulmonary mucormycosis	Yanfen Liu	Received

P-4228	Mucorales PCR in blood for early and non-invasive diagnosis of mucormycosis: a confronting case-series	Robina Aerts	Received

P-4239	Challenges in screening for Strongyloides: a case of delayed detection	Caitlin Trottier	Received

P-4262	A special cause of acute scrotum	Szofia Dr. Hajósi-Kalcakosz	Received

P-4264	Unmasking of visceral leishmaniasis in a patient with a haemophagocytic lymphohistiocytosis (HLH) syndrome in an endemic setting	Aida Mary Varghese	Received

P-4267	NGS-characterised infection with Dibothriocephalus latus after consumption of supermarket sushi, France	Marie Gladys Robert	Received

P-4275	One thing is certain on Bamako: everything is uncertain	Éva Lívia Nagy	Received

P-4279	Silent infective endocarditis (SIE): a new entity, a poor clinical evaluation or an incidental finding?	Luis Moltrasio	Received

34th ECCMID

27-30 April Barcelona

About us

Search and consult posters online
in an exclusive section
for each poster

ACTIVE FROM 27/04/2024 TO 27/04/2024

Poster
Gallery

Upload
Poster

Featured Poster

Vote poster

Poster Discussion
Forum



		Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress.

About us

Terms and Conditions

Special Access

Commercial Web Access